|
テニュアトラック着任後初めての幸谷ラボが主体となって行った仕事がBLOODにより受理。
Toyotaka Kawamata+, Jun Lu+, Tadayuki Sato+, Masafumi Tanaka, Hitoshi Nagaoka, Yasutoshi Agata, Takae Toyoshima, Kazuaki Yokoyama, Naoki Oyaizu, Naoya Nakamura, Kiyoshi Ando, Arinobu Tojo*, and Ai Kotani*. +equally contributed *corresponding author.
Imatinib mesylate directly impairs class switch recombination through downregulation of AID.
Blood. 2012 Mar 29;119(13):3123-7. |
|
|
|
|
Seo S, Nakamoto T, Takeshita M, Lu J, Sato T, Suzuki T, Kamikubo Y, Ichikawa M, Noda M, Ogawa S, Honda H, Oda H, Kurokawa M.
Cas-L regulates myeloid cell motility and suppresses progression of leukemia induced by p210Bcr/Abl.
Cancer Sci. 2011 Aug 16.
|
|
|
|
|
Harnprasopwat R+, Lodish HF,, Ha D, Toyoshima T, Tojo A and Kotani A*+
*correspondence author + equally contributed.
Alteration of processing induced by a single nucleotide polymorphism in pri-miR-126
Biochemical and Biophysical Research Communications 2010 Aug 20;399(2):117-22.
|
|
|
|
|
Kotani A, Ha D, Schotte D, den Boer ML, Armstrong SA, and Lodish HF
A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 Acute Lymphocytic Leukemia cells.
Cell Cycle 2010 Mar 18;9(6) |
|
|
|
|
Kotani A, Ha D, Hsieh J, Rao R, Schotte D,den Boer ML, Armstrong SA, and Lodish HF
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 Acute Lymphocytic Leukemia cells and exerts synergistic effects with miR-221 . Blood. 2009 Nov 5;114(19):4169-78. |
|
|
|
|
Kotani A, Hori T, Fujita T, Kambe N, Matsumura Y., Ishikawa T, Miyachi Y, Nagai K, Tanaka Y, and Uchiyama T
Involvement of OX40 ligand+ mast cells in chronic GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant.39(6):373-5, 2007 |
|
|
|
|
Kotani A, Kakazu N, Tsuruyama T, Okazaki IM, Muramatsu M, Kinoshita K, Nagaoka H, Yabe D and Honjo T
AID promotes B cell lymphomagenesis in Emu-cmyc Transgenic mice.
Proc Natl Acad Sci U S A. 104;1616-20. 2007 |
|
|
|
|
Kotani A, Okazaki IM, Muramatsu M, Kinoshita K, Begum NA, Nakajima T, Saito H and Honjo T.
A target selection of SHM is regulated similarly between T and B cells upon AID expression. Proc Natl Acad Sci U S A.102;4506-45611,2005 |
|
|
|
|
Kotani A, Takahashi A, Koga H, Morita R, Fukuyama H, Ichinohe T, Ishikawa T, Hori T, and Uchiyama T.
Myasthenia gravis after bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+CD4+T cells.
Eur. J. Haematol. 69:318-320, 2002. |
|
|
|
|
Kotani A, Hori T, Matsumura Y, and Uchiyama T. Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES/CCL5. Immunol. Lett. 84:1-7,2002. |
|
|
|
|
Kotani A, Ishikawa T, Matsumura Y, Ichinohe T, Ohno H, Hori T, and Uchiyama T:
Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation.
Blood 98(10):3162-3164, 2001. |
|
|
